cholestyramine powder for suspension

Product NDC: 67877-298
Requested package NDC: 67877-298-37
11-digit product format: 678770298
Labeler code: 67877
Product ID: 67877-298_a5b0d23a-e47d-491f-9602-a7836b97b13c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: cholestyramine powder for suspension
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: Ascend Laboratories, LLC
Application: ANDA211856
Marketing category: ANDA
Marketing start: 2021-10-20
Substance: CHOLESTYRAMINE
Active strength: 4 g/8.78g
Pharmacologic classes: Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A211856-001	CHOLESTYRAMINE	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB		2021-10-19
A211856-002	CHOLESTYRAMINE	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB		2021-10-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A211856-001	AB
A211856-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 70 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	A211856-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2021-10-19	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A211856-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2021-10-19	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 70 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A211856-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A211856-002	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A211856-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A211856-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A211856-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A211856-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211856-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211856-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A211856-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A211856-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211856-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211856-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211856-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211856-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211856-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211856-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211856-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211856-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211856-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211856-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211856-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211856-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A211856-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A211856-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211856-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211856-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211856-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211856-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211856-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211856-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A211856-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A211856-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211856-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211856-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A211856-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A211856-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A211856-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A211856-002	AB	1	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	A211856-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A211856-002	AB	1	`bb7c543d1eb4…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: cholestyramine powder for suspension
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CHOLESTYRAMINE	4 g/8.78g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
4B33BGI082	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
848943	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
430ac07e-8524-4dec-a599-b7ebc56d9563	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bafdcfac-da3a-43c4-81f4-296b60084636	Product name	6	20250623
e2db08c6-133f-4f4f-afb4-e90a2418d6f6	Product name	1	20230320
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906	Product name	7	20210625
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
11ed6f83-cdd2-4637-8379-b1a1d3ae3cde	Product name	1	20181101
86c45a79-b9f0-4476-a27c-6e10db098497	Product name	1	20180125
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
6084a4f4-5437-c9a5-caec-5361ee075a59	Product name	1	20140508
90c5639a-61b0-88d6-ddcf-21888e94869a	Product name	1	20140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
67877-298-09	cholestyramine powder for suspension	8.780 g in 1 POUCH	POWDER, FOR SUSPENSION	8.780	5
67877-298-37	cholestyramine powder for suspension	368.760 g in 1 JAR	POWDER, FOR SUSPENSION	368.760	5
67877-298-60	cholestyramine powder for suspension	60 in 1 CARTON	POWDER, FOR SUSPENSION	60	5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
67877-298-09	EA - Each	67877-298	ebcb4068-d230-41ca-8385-2a1dcb9644a3	1	2021-12-08
67877-298-37	GM - Gram	67877-298	98edd559-49e1-4863-80fe-e6f0b54f1a15	1	2021-12-08
67877-298-60	EA - Each	67877-298	45529c7a-54c8-4e12-9127-2c1a67b8d735	1	2021-12-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
67877-298	CHOLESTYRAMINE POWDER FOR SUSPENSION POWDER, FOR SUSPENSION [ASCEND LABORATORIES, LLC]	5	Current NDC, Legacy NDC, 3 package rows	20220708_430ac07e-8524-4dec-a599-b7ebc56d9563.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
cholestyramine powder for suspension	CHOLESTYRAMINE POWDER FOR SUSPENSION	Bryant Ranch Prepack	31d04422-f159-42ba-8eb5-b0ec1dbc52f9	2026-08-26	Adverse reactions	Exact identifier application applno (ANDA): 211856 application number: ANDA211856
cholestyramine powder for suspension	CHOLESTYRAMINE POWDER FOR SUSPENSION	Bryant Ranch Prepack	408ad775-9a1b-43cc-b122-226ade73e0c2	2026-08-25	Adverse reactions	Exact identifier application applno (ANDA): 211856 application number: ANDA211856
cholestyramine powder for suspension	CHOLESTYRAMINE POWDER FOR SUSPENSION	Bryant Ranch Prepack	5238dc45-a2b7-4208-b1a7-cc695b6cd1f0	2026-08-10	Adverse reactions	Exact identifier application applno (ANDA): 211856 application number: ANDA211856
cholestyramine powder for suspension	CHOLESTYRAMINE POWDER FOR SUSPENSION	Ascend Laboratories, LLC	430ac07e-8524-4dec-a599-b7ebc56d9563	2026-07-10	Adverse reactions	Exact identifier application applno (ANDA): 211856 application number: ANDA211856 ndc (package): 67877-298-37 ndc (product): 67877-298 ndc11 (package): 67877029837

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4B33BGI082	CHOLESTYRAMINE	11041-12-6	CHOLESTYRAMINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
848943	cholestyramine resin 4 GM Powder for Oral Suspension	PSN	5238dc45-a2b7-4208-b1a7-cc695b6cd1f0	108
848943	cholestyramine resin 4000 MG Powder for Oral Suspension	SCD	5238dc45-a2b7-4208-b1a7-cc695b6cd1f0	108
848943	cholestyramine resin 4 GM per 9 GM Powder for Oral Suspension	SY	5238dc45-a2b7-4208-b1a7-cc695b6cd1f0	108
848943	cholestyramine resin 4 GM Powder for Oral Suspension	SY	5238dc45-a2b7-4208-b1a7-cc695b6cd1f0	108
848943	cholestyramine resin 4 GM Powder for Oral Suspension	PSN	31d04422-f159-42ba-8eb5-b0ec1dbc52f9	101
848943	cholestyramine resin 4 GM Powder for Oral Suspension	PSN	408ad775-9a1b-43cc-b122-226ade73e0c2	101
848943	cholestyramine resin 4000 MG Powder for Oral Suspension	SCD	31d04422-f159-42ba-8eb5-b0ec1dbc52f9	101
848943	cholestyramine resin 4000 MG Powder for Oral Suspension	SCD	408ad775-9a1b-43cc-b122-226ade73e0c2	101
848943	cholestyramine resin 4 GM per 9 GM Powder for Oral Suspension	SY	31d04422-f159-42ba-8eb5-b0ec1dbc52f9	101
848943	cholestyramine resin 4 GM per 9 GM Powder for Oral Suspension	SY	408ad775-9a1b-43cc-b122-226ade73e0c2	101
848943	cholestyramine resin 4 GM Powder for Oral Suspension	SY	31d04422-f159-42ba-8eb5-b0ec1dbc52f9	101
848943	cholestyramine resin 4 GM Powder for Oral Suspension	SY	408ad775-9a1b-43cc-b122-226ade73e0c2	101
848943	cholestyramine resin 4 GM Powder for Oral Suspension	PSN	430ac07e-8524-4dec-a599-b7ebc56d9563	5
848943	cholestyramine resin 4000 MG Powder for Oral Suspension	SCD	430ac07e-8524-4dec-a599-b7ebc56d9563	5
848943	cholestyramine resin 4 GM per 9 GM Powder for Oral Suspension	SY	430ac07e-8524-4dec-a599-b7ebc56d9563	5
848943	cholestyramine resin 4 GM Powder for Oral Suspension	SY	430ac07e-8524-4dec-a599-b7ebc56d9563	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
67877-298-37	67877029837	368.76 g in 1 JAR (67877-298-37)	368.76 g	2021-10-20	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
cholestyramine powder for suspension - Bryant Ranch Prepack	Bryant Ranch Prepack	2026-08-26	HUMAN PRESCRIPTION DRUG LABEL	103
cholestyramine powder for suspension - Bryant Ranch Prepack	Bryant Ranch Prepack	2026-08-25	HUMAN PRESCRIPTION DRUG LABEL	102
cholestyramine powder for suspension - Bryant Ranch Prepack	Bryant Ranch Prepack	2026-08-10	HUMAN PRESCRIPTION DRUG LABEL	109
CHOLESTYRAMINE - Ascend Laboratories, LLC \| Alkem Laboratories Limited	Ascend Laboratories, LLC \| Alkem Laboratories Limited	2026-07-10	Human Prescription Drug Label	6
cholestyramine powder for suspension - Bryant Ranch Prepack	Bryant Ranch Prepack	2022-04-25	HUMAN PRESCRIPTION DRUG LABEL	101